C-Reactive Protein Testing Market Driven By Prevalence Of Gastrointestinal Diseases And Robust Disease Testing Protocols | Grand View Research, Inc.

July 26 17:31 2021
C-Reactive Protein Testing Market Driven By Prevalence Of Gastrointestinal Diseases And Robust Disease Testing Protocols | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to a new report published by Grand View Research, Extensive research conducted on various applications of the C-reactive protein (CRP) testing is one of the major factors driving the market.

The global C-reactive protein testing market size is expected to reach USD 1.9 billion by 2027, growing at a CAGR of 1.3% during the forecast period, according to a new report by Grand View Research, Inc. Several studies have shown the role of C-reactive proteins as an inflammatory marker in gastrointestinal diseases. This has accelerated the reliance on these proteins for the diagnosis of a disease like Crohn’s disease and acute pancreatitis. The initiatives undertaken by government agencies to increase awareness as well as uptake of point-of-care are factors driving the market.

The rising prevalence of gastrointestinal diseases coupled with subsequent demand for robust disease testing protocols has driven the market to a considerable extent. POC based CRP testing within healthcare settings and among patients drives market growth. For instance, the National Institute for Health and Care Excellence has recommended the usage of POC CRP testing in primary care for adult patients diagnosed with respiratory tract infections.

Increase in funds and investments for research entities that are engaged in performing research activities in this area, boost market progression. The National Institute for Health Research, the Wellcome Trust, and the Department for International Development are among the few funding agencies engaged in supporting C-reactive protein tests related research activities. 

Request a free sample copy or view summary of this [email protected] https://www.grandviewresearch.com/industry-analysis/global-c-reactive-protein-testing-market

C-Reactive Protein Testing Market Report Highlights

 Immunoturbidimetric assay segment accounted for the maximum revenue share in 2019 and is anticipated to maintain its dominance during the forecast period

This is attributive to the introduction of less expensive automated and highly sensitive immunoturbidimetric assays that have a wide measuring range for CRP levels

High sensitivity C-reactive protein accounted for the major revenue share in 2019 owing to their efficiency in delivering results with high accuracy as compared to the conventional assays

CRP is one of the important biomarkers that play a direct role in promoting vessel damage, vascular inflammation, and other clinical cardiovascular events

This has resulted in the high adoption rate of these tests for the detection of cardiovascular diseases, as compared to other disease areas

The high usage rate of these tests within clinical settings is attributive to the largest revenue share of clinics due to an increase in the number of patient visits in clinics

The clinics, including physician offices, outpatient clinics, and community health centers conduct these tests at an affordable cost in minimal time, resulting in the largest share

North America dominated the C-reactive protein testing market due to the presence of agencies, such as the American College of Cardiology Foundation, which raises awareness for the preliminary screening of inflammatory disorders, thereby positively influencing the uptake of these tests

Asia Pacific is anticipated to witness the fastest CAGR owing to the ongoing research studies pertaining CRP testing in the Asian countries, which promotes the adoption of these tests in this region

Quest Diagnostics, Siemens, Danaher, Abbott, Roche, and Thermo Fisher Scientific are some key companies operating in the market

These companies are expanding their product portfolio and distribution network through partnership and agreement models to reinforce their market presence.

For instance, in May 2018, Ortho Clinical Diagnostics signed an agreement with Sentinel Diagnostics to develop CRP Ultra (MP) Assay for future CRP testing in hospitals and laboratories.

For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/global-c-reactive-protein-testing-market/request/rs15

C-Reactive Protein Testing Market Segmentation

Grand View Research has segmented the global C-reactive protein testing market on the basis of assay type, detection range, disease area, end use, and region:

C-reactive Protein Testing Assay Type Outlook (Revenue, USD Million, 2016 – 2027)
    • Immunoturbidimetric Assay
    • ELISA
             • Clinical
             • Non-clinical
    • Chemiluminescence Immunoassay
    • Others

C-reactive Protein Testing Detection Range Outlook (Revenue, USD Million, 2016 – 2027)
    • hs-CRP
    • Conventional CRP
    • cCRP

C-reactive Protein Testing Disease Area Outlook (Revenue, USD Million, 2016 – 2027)
    • Cardiovascular Diseases
    • Cancer
    • Rheumatoid Arthritis
    • Inflammatory Bowel Disease
    • Endometriosis
    • Lupus
    • Others

C-reactive Protein Testing End-use Outlook (Revenue, USD Million, 2016 – 2027)
    • Clinics
             • By Entity
                         • Physician Offices
                         • Small Clinics
                         • Others
             • By Settings
                         • Urban Setting
                         • Rural Setting
    • Hospitals
                         • Urban Setting
                         • Rural Setting
    • Laboratories
                         • Urban Setting
                         • Rural Setting
    • Assisted Living Healthcare Facilities
                         • Urban Setting
                         • Rural Setting
    • Home
    • Others

C-reactive Protein Testing Regional Outlook (Revenue, USD Million, 2016 – 2027)
     North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • The U.K.
    • Asia Pacific
        • China
        • India
    • Central and South America
        • Brazil
    • Middle East & Africa (MEA)
        • South Africa

Fill The Pre-Order Enquiry Form For The Report @ https://www.grandviewresearch.com/inquiry/1956/ibb


About Grand View Research

Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/global-c-reactive-protein-testing-market